These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17606307)

  • 21. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
    Legro RS; Castracane VD; Kauffman RP
    Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Insulin resistance in obese and non-obese patients with polycystic ovary syndrome. Possible role in the pathogenesis of the disease].
    Vagiri D; Barletta C; Cioli I; Scavo D
    Minerva Endocrinol; 1994 Mar; 19(1):5-12. PubMed ID: 8035770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The insulin-resistant phenotype of polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L
    Fertil Steril; 2010 Aug; 94(3):1052-8. PubMed ID: 19580964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.
    Tan BK; Adya R; Farhatullah S; Lewandowski KC; O'Hare P; Lehnert H; Randeva HS
    Diabetes; 2008 Apr; 57(4):801-8. PubMed ID: 18174521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].
    Tao MF; Zhu JP; Zhou J; Lu W; Qin W; Teng YC; Jia WP
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):659-63. PubMed ID: 19595057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
    Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H; Takahashi K; Miyazaki K
    Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
    Harrison CL; Stepto NK; Hutchison SK; Teede HJ
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):351-7. PubMed ID: 21711376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.
    Vgontzas AN; Trakada G; Bixler EO; Lin HM; Pejovic S; Zoumakis E; Chrousos GP; Legro RS
    Metabolism; 2006 Aug; 55(8):1076-82. PubMed ID: 16839844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
    Onalan G; Goktolga U; Ceyhan T; Bagis T; Onalan R; Pabuçcu R
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):204-11. PubMed ID: 16316811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome.
    Seow KM; Juan CC; Ho LT; Hsu YP; Lin YH; Huang LW; Hwang JL
    Hum Reprod; 2007 Apr; 22(4):1100-6. PubMed ID: 17208941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Kandaraki E; Piouka A; Papavassiliou AG; Panidis D
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):634-41. PubMed ID: 18363886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta cell function and insulin sensitivity in women with polycystic ovary syndrome: influence of the family history of type 2 diabetes mellitus.
    Vrbikova J; Bendlova B; Vankova M; Dvorakova K; Grimmichova T; Vondra K; Pacini G
    Gynecol Endocrinol; 2009 Sep; 25(9):597-602. PubMed ID: 19572227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Glucose and lipid metabolism in patients with polycystic ovary syndrome].
    Ge XL; Lou SZ; Shen HM
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):527-30, 573. PubMed ID: 7835128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative diagnostic characteristics of carbohydrate metabolism disorders in women with polycystic ovary syndrome (PCOS)].
    Orbetsova M; Orbetsova V; Kamenov Z; Kolarov G; Andreeva M; Genchev G; Zakharieva S; Borisov I
    Akush Ginekol (Sofiia); 2003; 42(4):10-5. PubMed ID: 14577361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome.
    Savastano S; Orio F; Palomba S; Cascella T; Manguso F; Lupoli GA; Formisano P; Lombardi G; Colao A; Beguinot F; Valentino R
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):557-62. PubMed ID: 17590172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.